83915-83-7, 76547-98-3 Lisinopril dihydrate AKSci J10628
 
 
Loading Please Wait...
  J10628    AKSci Reference Standard
Lisinopril dihydrate, >98% (HPLC)
 
(S)-1-[N2-(1-carboxy-3-phenylpropyl)-lysyl-proline dihydrate
MK-521
IDENTITY
CAS Number:83915-83-7, 76547-98-3
MDL Number:MFCD01698825
MF:C21H31N3O5.2H2O
MW:441.52
EINECS:278-488-1
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:>98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:172-176°C
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Soluble in water (>10mg/mL) or DMSO (6.5mg/mL)

REVIEW
 Lisinopril was the third ACE inhibitor (after captopril and enalapril) and was introduced into therapy in the early 1990s. A number of properties distinguish it from other ACE inhibitors: It is hydrophilic, has a long half-life and tissue penetration, and is not metabolized by the liver. Lisinopril is the lysine-analog of enalapril. Unlike other ACE inhibitors, it is not a prodrug and is excreted unchanged in the urine.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

Current as of March 21, 2023

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS Request COA

⚠️
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.


CATEGORIES
 APIs and Bioactives > ACE Inhibitors


PubChem